Stem cells in regenerative medicine : science, regulation and business strategies /
| Άλλοι συγγραφείς: | , , , |
|---|---|
| Μορφή: | Ηλ. βιβλίο |
| Γλώσσα: | English |
| Έκδοση: |
Hoboken, NJ :
John Wiley & Sons, Ltd,
2015.
|
| Θέματα: | |
| Διαθέσιμο Online: | Full Text via HEAL-Link |
Πίνακας περιεχομένων:
- Therapeutic stem cells answer a strategic breakthrough need of healthcare / Alain Vertes
- Ethical considerations on the research and business of stem cells / Ljiljana Minwalla
- Projected growth of the worldwide stem cell market / Ed Field
- Cell therapy manufacturing: identifying and meeting demand / Jessica Carmen, David A. Brindley, Natasha L. Davie and David Smith
- The history of stem cell transplantation / Hilliard M. Lazarus and Stan Gerson
- Regulatory and intellectual property considerations for therapeutic human stem cell-based regenerative medicine product development: a U.S. perspective / Michael Mendicino and Darin Weber
- The regulation of stem cells in the UK and EU / Alex Denoon, Julian Hitchcock and James Lawford Davies
- The business of stem cell research tools / Erik Miljan
- Stem cell-derived cardiomyocytes and hepatocytes as tools for drug development and screening applications / Kate Camerona, Howard Marriage, David Haya and Claire Medine
- Stem cell tools for compound development / Tom Novak
- Stem cell origin of cancer: prospects for functional therapeutics and regenerative medicine / Vinagolu K. Rajasekhar
- The market of stem cell medicines for domestic and high value animals / Bob J. Harmann
- Stem cells veterinary medicines: a conceptual approach / John Peroni and Lindsey Boone
- Stem cells in veterinary medicines: a practical approach / Bob J. Harmann
- Stem cell veterinary medicines as success signals towards human stem cell therapeutics / Alain Vertes
- Animal models in regenerative medicine / Andrew N. Bubak, John D. Elsworth and John R. Sladek, Jr.
- Stem cell characterization: a guide to stem cell types, technologies, and future applications / Justin Lo Re, Rezma Shrestha and Leonard Sciorra
- Stem cell value chains / Judy Muller-Cohn, Paul Diaz and Rolf Muller
- Stem cell culture processes / Ravali Raju, Shikha Sharma and Wei-Shou Hu
- Indication transformation maps and the challenge of live cells delivery / Bob Deans and Lee Babiss
- Delivery and targeting of therapeutic cells / Paul Lin, Arnold I. Caplan and Erkki Ruoshlati
- Hematopoietic stem cells / Steve Wolpe and Lynnet Koh
- MSCs: the new medicince / Arnold Caplan
- Innovation and commercialization of induced pluripotent stem cells / Shintaro Sengoku
- Embryonic stem cells / Rachel Eiges, Benjamin E. Reubinoff and Charles Irving
- Allogeneic versus autologous stem cell transplantation in regenerative medicine / Kathy Trzaska-Accurso and Pranela Rameshwar
- Clinical immunological barriers to regenerative medicine: do they matter? / Cristina Trento and Francesco Dazzi
- Challenges in the clinical development of stem cells / John Caulfield
- Pricing and reimbursement of regenerative medicines / Nathan Dowden
- The role of patient advocacy in the clinical translation of regenerative medicine / Bernard Siegel and Alan Jakimo
- Financing strategies for regenerative medicine start-ups / Carol Julie Walton, Lee Buckler and Gregory A. Bonfiglio
- Strategic alliances, mergers and acquisitions in regenerative medicine / Nafees N. Malik, Timothy E. Allsopp and Devyn M. Smith
- History of monoclonal antibodies and lessons for the development of stem cell therapeutics / Alain Vertes and Nathan Dowden
- Deployment of stem cell technologies in industry and healthcare/ Alain Vertes.
